Type 2 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People with Type 1 diabetes who are not taking cholesterol-lowering medications, omega fatty acid supplements, or a specific class of diabetes medication called thiazolidinediones, and who have no signs or test results suggesting heart disease
- People with Type 2 diabetes who are not taking omega fatty acid supplements or thiazolidinediones, and who have no signs or test results suggesting heart disease
- People with higher-than-normal fasting blood sugar levels who are scheduled to have a glucose tolerance test (a test that checks how the body processes sugar)
- People who are booked in for weight-loss (bariatric) surgery
- Healthy volunteers who have no major ongoing or serious illnesses, are not taking regular medications or omega fatty acid supplements, and have no known heart disease
- People aged between 20 and 75 years (male or female)
- People who are able to understand and agree to the consent process for joining a research study
Who may not be able to join:
- People with Type 1 diabetes who are taking cholesterol-lowering medications, thiazolidinediones, or omega fatty acid supplements
- People with Type 1 or Type 2 diabetes who have a history of, or heart test results showing, signs of coronary heart disease
- People with Type 2 diabetes who are taking thiazolidinediones or omega fatty acid supplements
- Healthy volunteers who have any history of heart disease, poor blood circulation, or diabetes
- Anyone taking cholesterol-lowering medications or omega fatty acid supplements (for the healthy volunteer group)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Handrean Soran, MD FRCP, Manchester University NHS Foundation Trust
Phone: 01612764843
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Paraoxonase activity is measured using a semi-automated microtitre plate method.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.